Please login to the form below

Not currently logged in
Email:
Password:

Healthcare at Home and QED partner on orphan diseases

OrphanReach alliance will see companies provide product lifecycle services

Healthcare at Home and QED Clinical Services have formed a strategic alliance under the OrphanReach banner to support the launch of products for rare and orphan diseases.

Homecare and patient support company Healthcare at Home and QED Clinical Services, a clinical research organisation (CRO), said the alliance would serve a unique market with a unique proposition.

Mike Gordon, CEO for Healthcare at Home, said: “OrphanReach will solve some key problems facing biopharmaceutical companies launching new medicines. It will ensure that pre-launch plans are data rich, evidence based and patient focused. It will ensure that market access is optimised and product launches are as successful as can be.”

Services offered by the UK firm's new OrphanReach alliance will include clinical support and integrated patient management with an ambition to provide “the most integrated clinical development programme and launch plan within rare and orphan conditions”.

Healthcare at Home has 15 years' experience of working in rare and orphan diseases and has supported the launch of many products across Europe, where it has been tasked with services that include running homecare arms in clinical trials.

Meanwhile, global CRO QED was founded in 2002 and has worked on more than 70 rare disease projects.

Its CEO, Thomas Ogorka, said: “We are delighted to be working alongside Healthcare at Home in this strategic alliance. We have a rich track record of optimising clinical development within rare and orphan markets and this alliance enables QED to take the range of services we can offer to a new level but more importantly support clients in a far deeper and more strategic way.”

21st May 2013

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics